Article

Genomic expression of MSR1 in solid tumors associates with response to anti-PD1 and anti-CTLA4 therapies

2023-06-06

Abstract excerpt

<title>Abstract</title> <p>Immuno-oncology has gained momentum with the approval of antibodies that have demonstrated clinical activity in different indications. Unfortunately, for anti PD (L)1 agents in monotherapyonly half of the treated population will achieve a clinical response. For other agents like anti-CTLA4 antibodies, no biomarker exists, and tolerability can limit the administration of this compound. I...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 26a198fe-1b5a-5f15-87fb-7627d6a6828a
DOI: 10.21203/rs.3.rs-3005010/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Genomic expression of MSR1 in solid tumors associates with response to anti-PD1 and anti-CTLA4 therapiesDOI 10.21203/rs.3.rs-3005010/v1Read

Pan-cancer analysis reveals potential for synergy between SERPINA1 molecular targeting and macrophage-related immunotherapySemantic proximity Read

The multi-omics landscape and clinical relevance of the immunological signature of phagocytosis regulators: Implications for risk classification and frontline therapies in skin cutaneous melanomaSemantic proximity Read

Novel Macrophage Subtype Genes for Predicting Prognosis and Immunotherapy Response in Melanoma Based on Single-Cell and Bulk RNA Sequencing AnalysisSemantic proximity Read

Bexmarilimab-induced macrophage activation leads to treatment benefit in solid tumors: the phase I/II first-in-human MATINS trialSemantic proximity Read

A gene expression signature of TREM2hi macrophages and γδ T cells predicts immunotherapy responseSemantic proximity Read

Prognostic value of CD163+ macrophages in solid tumor malignancies: A scoping reviewSemantic proximity Read

SIGLEC1 FACILITATES MACROPHAGE-CD8 <sup>+</sup> T CELL INTERACTIONS AND CORRELATES WITH CANCER IMMUNOTHERAPY RESPONSESemantic proximity Read

Harnessing Inflammatory Monocytes to Overcome Resistance to Anti-PD-1 ImmunotherapySemantic proximity Read

RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous MelanomaSemantic proximity Read

Thirteen tumor necrosis factor receptor superfamily gene expression in malignancies and their clinical relevance to immunotherapy: a pan-cancer analysisSemantic proximity Read

TLR4 exhibits a Pivotal Role in Immuno-Oncology through Systematic Pan-Cancer AnalysisSemantic proximity Read

Apolipoprotein C1 as a Novel Biomarker for Evaluating Immunotherapy Drug Responses and Clinical Prognosis for Microsatellite Unstable Colorectal CancerSemantic proximity Read